Companies /Healthcare

Nurix Therapeutics Inc

NASDAQ: NRIX Biotechnology
$25.44
▼ $0.06 (−0.24%) today
Markets closed · 11:42pm ET

Earnings History & Trends

EPS and revenue vs. Street estimates · SEC filings
40%
EPS beat rate
+0.71%
Avg. EPS surprise
Consecutive EPS misses
NRIX vs Market · 30-day return after each reportNRIXS&P 500
−20%0%+20%−23.8%+1.6%Q2 25+31.8%+4.6%Q3 25−10.1%−2.0%Q4 25+5.9%+9.1%Q1 26+4.8%+2.8%Q2 26
−20%0%+20%Q2 25Q3 25Q4 25Q1 26Q2 26
NRIX EPS Trend · estimate vs actualEstimateActual
$-0.90$-0.60$-0.30$-0.74$-0.52Q2 25$-0.85$-1.03Q3 25$-0.92$-0.82Q4 25$-0.76$-0.79Q1 26$-0.72$-0.81Q2 26
$-0.90$-0.60$-0.30Q2 25Q3 25Q4 25Q1 26Q2 26
NRIX Revenue Trend · estimate vs actualEstimateActual
$0$20.0M$40.0M$17.5M$44.1MQ2 25$16.1M$7.9MQ3 25$13.4M$13.6MQ4 25$14.2M$6.3MQ1 26$15.3M$9.0MQ2 26
$0$20.0M$40.0MQ2 25Q3 25Q4 25Q1 26Q2 26

Quarter by Quarter

Quarter EPS · est. Surprise Revenue · est. Surprise
Q2 2026 $-0.81 est. $-0.72 −13.07% $9.0M est. $15.3M −40.85%
Q1 2026 $-0.79 est. $-0.76 −3.32% $6.3M est. $14.2M −56.09%
Q4 2025 $-0.82 est. $-0.92 +10.85% $13.6M est. $13.4M +1.22%
Q3 2025 $-1.03 est. $-0.85 −21.08% $7.9M est. $16.1M −50.85%
Q2 2025 $-0.52 est. $-0.74 +30.15% $44.1M est. $17.5M +151.56%

Figures from SEC filings and company reports. Not investment advice.